SOX11 and glioblastoma: Korkolopoulou et al. showed that SOX11 overexpression was correlated with improved overall survival in GBM, presenting SOX11 tissue expression as an independent marker of favorable outcome, supporting its tumor suppressor function in astroglial tumors [49].